Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Background: Endometriosis is a chronic inflammatory condition affecting up to 10% of the female population. Management often involves surgical treatment with excision or ablation of lesions. Aim: To evaluate the surgical outcomes and complications rates of endometriosis related laparoscopic surgery. Materials and Methods: A retrospective review of all women who underwent endometriosisrelated surgery over an eight-year period in a multicenter gynecological unit. Results: A total of 972 patients met the inclusion criteria. Six hundred and fifty-eight (67.9%) women had Stage 1 or 2 endometriosis and 314 (32.1%) had stage 3 or 4 endometriosis. The patients with stage 3 or 4 endometriosis were more likely to have longer operative times (105 vs. 65 minutes, p = 0.001), more likely to require a conversion to laparotomy (12 vs. 6 p=.002) and were more likely to suffer from a complication (16 vs. 9, p = 0.003). The stage of endometriosis was found to be the only independent variable related to surgical complications and conversions to laparotomy. Conclusion: Surgery is an effective treatment option for all women with endometriosis, however it is significantly more effective in women with moderate to severe endometriosis, although they are at higher risk of complications.